Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125563321 | 12556332 | 1 | I | 20160629 | 20160708 | 20160714 | 20160714 | EXP | GB-ABBVIE-16P-167-1675780-00 | ABBVIE | 65.00 | YR | M | Y | 117.00000 | KG | 20160714 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125563321 | 12556332 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | U | UNKNOWN | 50662 | |||||||||
| 125563321 | 12556332 | 2 | C | ADALAT | NIFEDIPINE | 1 | 0 | 1 | DF | QD | |||||||||
| 125563321 | 12556332 | 3 | C | ALPHOSYL | 2 | 0 | 1 | DF | QD | ||||||||||
| 125563321 | 12556332 | 4 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | INTRA-AURAL | 0 | 1 | GTT | TID | ||||||||
| 125563321 | 12556332 | 5 | C | FYBOGEL | PLANTAGO OVATA SEED | 1 | USE AS DIRECTED | 0 | |||||||||||
| 125563321 | 12556332 | 6 | C | GENTAMICIN. | GENTAMICIN | 1 | 8 DROPS (APPLY DROPS BILATERAL) | 0 | 2 | GTT | QID | ||||||||
| 125563321 | 12556332 | 7 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | 2 AD (APPLY THINLY TO THE AFFECTED AREA(S)) | 0 | 1 | DF | BID | ||||||||
| 125563321 | 12556332 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | 1 | DF | QD | |||||||||
| 125563321 | 12556332 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 1 AD (HAVE ROUTINE BLOOD TESTS) | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125563321 | 12556332 | 1 | Product used for unknown indication |
| 125563321 | 12556332 | 2 | Product used for unknown indication |
| 125563321 | 12556332 | 3 | Product used for unknown indication |
| 125563321 | 12556332 | 4 | Product used for unknown indication |
| 125563321 | 12556332 | 5 | Product used for unknown indication |
| 125563321 | 12556332 | 6 | Product used for unknown indication |
| 125563321 | 12556332 | 7 | Product used for unknown indication |
| 125563321 | 12556332 | 8 | Product used for unknown indication |
| 125563321 | 12556332 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125563321 | 12556332 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125563321 | 12556332 | Lethargy | |
| 125563321 | 12556332 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125563321 | 12556332 | 1 | 20160317 | 0 | ||
| 125563321 | 12556332 | 2 | 20150506 | 0 | ||
| 125563321 | 12556332 | 3 | 20150506 | 0 | ||
| 125563321 | 12556332 | 4 | 20160505 | 20160519 | 0 | |
| 125563321 | 12556332 | 5 | 20150907 | 0 | ||
| 125563321 | 12556332 | 6 | 20160428 | 20160505 | 0 | |
| 125563321 | 12556332 | 7 | 20160428 | 20160526 | 0 | |
| 125563321 | 12556332 | 8 | 20150506 | 0 | ||
| 125563321 | 12556332 | 9 | 20150506 | 0 |